BioPharmGuy logo
Sponsored By:
Trianni Inc.
Weekly Update Subscription
Emery Pharma
Celltech is defunct.

Fate: Purchased by UCB, May 2004, $2.7B


------------------
If you believe any of this information is incorrect, please let us know.